Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$599K Buy
2,772
+145
+6% +$27.7K 0.02% 379
2026
Q1
$482K Buy
2,627
+7
+0.3% +$1.29K 0.03% 374
2025
Q4
$461K Sell
2,620
-4
-0.2% -$653 0.04% 378
2025
Q3
$368K Buy
2,624
+113
+5% +$15.3K 0.03% 431
2025
Q2
$315K Buy
2,511
+10
+0.4% +$1.25K 0.08% 151
2025
Q1
$342K Hold
2,501
0.1% 126
2024
Q4
$382K Buy
+2,501
New +$422K 0.16% 117

Other funds holding BIIB

Tema ETFs's BIIB Position: Q2 2026 in Review

Tema ETFs increased its Biogen (BIIB) stake by 5.5% in Q2 2026, buying an estimated $27.7K and bringing the position to 2,772 shares worth $599K. The position accounts for 0.02% of the portfolio, ranked #379.

Tema ETFs first reported a position in BIIB in Q4 2024 and has held it in 7 quarters since. 135 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Tema ETFs held 2,772 shares of Biogen worth $599K as of Q2 2026.
  • Tema ETFs bought 145 Biogen shares in Q2 2026, an estimated $27.7K.
  • Biogen made up 0.02% of Tema ETFs's portfolio in Q2 2026, its #379 holding.
  • Tema ETFs first reported a position in Biogen in Q4 2024 and has held it in 7 quarters since.
  • 135 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Tema ETFs's 13F filing for Q2 2026, filed 10 Jul 2026.